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Abstract
In most industrialized countries, different epidemiologic studies show that chronic renal failure is dramatically increasing.
Such major public health problem is a consequence of acquired systemic diseases such as type II diabetes, which is now the
first cause for end stage renal failure. Furthermore, lithogenic diseases may also induce intratubular crystallization, which
may finally result in end-stage renal failure (ESRF). Up to now, such rare diseases are often misdiagnosed. In this study, based
on twenty four biopsies, we show that SR mFTIR (Synchrotron Radiation-mFourier transform infrared) spectroscopy
constitutes a significant opportunity to characterize such pathological mcalcifications giving not only their chemical
composition but also their spatial distribution in the tissues. This experimental approach offers new opportunities to the
clinicians to describe at the cell level the physico-chemical processes leading to the formation of the pathological
calcifications which lead to ESRF.
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Introduction
Chronic renal failure is increasing in most industrialized
countries as a consequence of acquired systemic diseases such as
type II diabetes, which is now the first cause for end stage renal
failure [1]. A number of other causes may be responsible for the
loss of kidney function and tubular interstitial nephritis, but they
are less frequent [2,3]. Among them, lithogenic diseases may
induce intratubular crystallization, which may finally result in end-
stage renal failure (ESRF). The diagnosis of such pathological
conditions is of a prime importance before kidney transplantation
in order to treat efficiently the disease and protect the grafted
kidney against recurrence of crystallization. Unfortunately, such
rare diseases are often misdiagnosed. The main consequence in
affected patients is the progressive degradation of the kidney
function which ends up in dialysis [4]. Often, crystals are found in
kidney biopsies performed in order to understand the mechanism
of the loss of renal function. However, only few histochemical tests
are available to attempt an identification of the crystals. More-
over, in some cases, common crystals such as calcium oxalate
monohydrate may be present as a consequence of renal failure, but
they are not involved in the kidney loss. For these reasons, it is of
clinical importance to accurately identify crystals found in the
tissue as they can help to early characterization of a disease, which
may be efficiently treated by specific drugs. To the best of our
knowledge, very few papers have focussed on such subject and
only few crystalline phases have been already reported [5,6].
The aim of this work is to emphasize the chemical diversity of
ectopic calcifications present in kidney tissue. In some cases,
crystals in tissues are very tiny and classical FTIR microscopy is
not sensitive enough to identify their chemical composition. In
those cases, Synchrotron Radiation–Fourier Transform Infrared
microspectroscopy (mSR-FTIR) can be performed, such technique
being able to collect infrared spectra on microscopic-sized
minerals present in biopsies. Combined with optical microscopic
and raster scanning, chemical cartography obtained with SR-
spectroscopy can be associated to an optical image. This
experimental configuration allowed us to study different biopsies.
Such information regarding the chemical composition of ectopic
calcifications will provide insight into the mechanisms leading to
the loss of the kidney function.
Materials and Methods
Samples
Twenty-four kidney biopsies were investigated. The biological
samples came from Necker Hospital (Paris- France). Five microns
slices of the biopsies were deposited on low-e microscope slides
(MirrIR, Kevley Technologies, Tienta Sciences, Indianapolis). For
tissue embedded in paraffin, the paraffin was chemically removed
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Ethical approval was obtained by the ethical committee of Necker
Hospital for this study. Each sample was only named by a study
number, without indication of the name of the patient or potential
identification data. The ethical committee of Necker Hospital had
approved this consent procedure.
Synchrotron FTIR microspectroscopy
The FTIR measurements were carried out at SOLEIL-
Synchrotron (St Aubin-Gif sur Yvette, France) on the SMIS
beamline [7]. The IR microspectroscopic mappings were collected
in reflection mode using an Infrared microscope (Nicplan-
Thermo Nicolet) coupled to a FTIR spectrometer (Magma 550-
Thermo-Nicolet). The IR microscope is equipped with a
motorized sample stage (precision 1 mm) and a liquid nitrogen
cooled mercury cadmium telluride (MCT- 250 mm) detector. Most
of the analysis and maps presented here were achieved with a
projected area on the sample of 666 mm
2 and a step size of 6 mm,
and each spectrum was acquired after 64 accumulations at 8 cm
21
spectral resolution. Data acquisition and processing was performed
using Omnic software (Version 7.4, Thermo-Scientific). The
compounds were identified by comparing them to reference
spectra [8].
Results
Selected examples of infrared spectra from biopsies are
presented in Figure 1. Due to the high brilliance of the
synchrotron source, the signal to noise ratio is excellent. Taking
advantage of the small size of the probe, it was possible to select a
small area of the biopsy for infrared spectra collection and thus to
obtain a high quality spectrum of the crystals. Several chemical
phases have been identified including amorphous silica through its
infrared band at 1102 cm
21 (Figure 1a), sodium hydrogen urate
monohydrate through its specific bands at 3600 and 1004 cm
21
(Figure 1b), and several calcium phosphates including whitlockite
(peaks at 1080, 1025 cm
21 and associated shoulders, Figure 1c),
octacalcium phosphate and carbapatite (Figure 1d).
Figure 1. Selected examples of infrared spectra from biopsies. a) Amorphous silica identified by a band at 1102 cm
21, b) sodium hydrogen
urate monohydrate identified by specific bands at 3600 and 1004 cm
21, c) several calcium phosphates including whitlockite (peaks at 1080,
1025 cm
21 and associated shoulders, d) octacalcium phosphate and carbapatite, identified by a shoulder at 1119 cm
21, e) normal tissue, with signal
of water (3300 cm
21 and peaks around 1600 cm
21) and proteins (peaks at 2900 cm
21).
doi:10.1371/journal.pone.0028007.g001
Table 1. Different chemical phases identified in this study.
Samples Sex–age (years) Clinical data Chemical phase identified
B85 M - 33 Acute renal failure (ARF) Methyl-1 uric acid
B162 M - 72 Chronic renal failure (CRF) Whewellite ..Weddellite
B163 M - 72 End stage renal failure (ESRF) Whewellite
B164 M Renal papilla Carbapatite .. amorphous carbonated calcium phosphate (ACCP)
B165 M Renal papilla Sodium hydrogen urate monohydrate, Carbapatite and Whitlockite
B166 F - 53 CRF Dihydroxyadenine
B167 M ARF Whewellite
B170 F - 39 CRF Proteins (amylose)
B171 M - 58 CRF Whewellite
B173 M - 48 CRF Carbapatite+whewellite
B174 M - 50 ARF Proteins
B175 M - 73 CRF, hypercalcemia Octacalcium phosphate pentahydrate
B176 M - 66 CRF Whewellite
B177 F - 39 Diabetes - CRF Silicium dioxide (amorphous Silica)
B178 M - 55 ARF Dihydroxyadenine
B179 M - 48 ESRF=. Kidney transplantation (KT)=. CRF Dihydroxyadenine
B180
* M – 51 ESRF=. KT=. CRF Dihydroxyadenine
B181
** M - 51 ESRF=. KT=. CRF Dihydroxyadenine
B182 M - 26 ESRF=. KT=. CRF Carbapatite and octacalcium phosphate pentahydrate
B183 F - 52
Diabetes=. ESRF=. KT=. CMV
infection=.ARF
Foscarnet and carbapatite
B184 M - 40 ESRF=. KT Whewellite
B189 F Diabetes=. ESRF=. KT=. CRF Whewellite
B191 M - 74 ESRF=. KT=. CRF Calcite, whewellite
B192 F - 68 CRF, hypercalcemia Carbapatite, amorphous calcium phosphate
*Two years after kidney transplantation.
**Five years after kidney transplantation; same patient as for B180. Both biopsies were received in the same time.
doi:10.1371/journal.pone.0028007.t001
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species were identified and in two cases, precipitates of proteins in
tubular lumens were observed. Among crystalline compounds,
calcium oxalate was observed commonly as whewellite and in one
case as weddellite, which was found as a minor phase in a biopsy
containing large amounts of whewellite. Several calcium phos-
phates were identified: the most common phase was carbapatite.
Amorphous carbonated calcium phosphate (ACCP), octacalcium
phosphate pentahydrate (OCP) and whitlockite were observed
more scarcely. In one sample, some crystals of calcite were
observed in association with whewellite. Among the other
crystalline species, several purines were identified: sodium
hydrogen urate monohydrate, dihydroxyadenine and methyl-1
uric acid. Lastly, foscarnet, a drug used against cytomegalovirus
infection, was found in glomeruli in one patient.
By performing infrared mapping of selected areas of the biopsy,
we were able to identify at least 2 different crystalline species in the
same sample for 7 biopsies (27%), example in Figure 2 shows a
representative example and even three compounds in one case.
Finally, in Figure 3, an optical image of a kidney biopsy shows
the glomerulus containing very refringent crystals and the
proximal tubules close to the glomerulus, in which pathological
deposits were also observed (Fig. 3a). The small size of the probe
allowed us to characterize separately the phases deposited in the
glomerulus and in the wall of the tubules. The crystals
agglomerated in the glomerulus were identified as sodium
foscarnet (Fig. 3b). In contrast, deposits within in the cells of the
proximal tubules were made of apatite (Fig. 3c).
Discussion
Crystal deposits within the kidney tissue may occur as a
consequence of genetic disorders such as primary hyperoxaluria,
adenine phosphoribosyltransferase deficiency, distal renal tubular
acidosis, Dent’s disease, acquired diseases such as primary
hyperparathyroidism, Sjo ¨gren’s syndrome or intoxication with
ethylene glycol which leads to renal failure due to calcium salts
deposition.
Classical characterisation of intratissular calcification performed
at the hospital is based on tissue coloration with von Kossa and
alizarin dyes. These methods help to identified Ca
2+ oxalate and
Ca
2+ phosphate deposits but are not able to separate whewellite
and weddellite or the different Ca
2+ phosphates namely whitlock-
ite, brushite or apatite.
Through classical FTIR investigation of 25 biopsies, Estepa-
Maurice, et al. have underlined the presence of seven chemical
phases (whewellite, weddellite, carbapatite, anhydrous uric acid,
brushite, dihydroxyadenine and 49-hydroxytriamterene sulfate)
[6]. Thanks to the high flux of synchrotron radiation, micrometer
scale calcifications have been characterized. This technique was
especially required for analysis of very small crystals (less than
10 mm). Previous experiments [6] were performed on larger
crystals (more than 15 mm). Another advantage of synchrotron
radiation was its very high signal-to-noise ratio, since such
measurements could be the base for a medical diagnosis. Samples
could be sent to synchrotrons and that once specific markers are
found, then benchtop spectrometers can be used for next
measurements. A striking point of our investigation comes from
the fact that six new chemical phases have been identified
including amorphous silica, sodium hydrogen urate, methyl-1 uric
acid and three different Ca
2+ phosphates namely whitlockite, OCP
and ACCP. Moreover, for the first time, mappings with a
10610 mm
2 probe have allowed us to underline the chemical
heterogeneity of intratissular calcifications. Among the 24 samples
which corresponded to 23 patients (B180 and B181 samples
correspond to two successive biopsies for the same patient
performed two and five years after kidney transplantation), 8
samples contained two to three different crystalline phases.
For the Ca
2+ phosphates we have already underlined the clinical
interest to distinguish the different crystalline species in kidney
Figure 2. Optical image and mapping of BR165 biopsy (scale from blue to red with increasing concentration), and FT-IR spectra of
crystals. a) Optical image of BR165, b) carbapatite map (done at 1030 cm
-1), c) sodium hydrogen urate monohydrate map (done at 3600 cm
-1), d)
FT-IR spectra of those compounds.
doi:10.1371/journal.pone.0028007.g002
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component and has been associated with chronic urinary tract
infection in most calculi in women [9]. In contrast, brushite was
often associated with hypercalciuria [10] and primary hyperpara-
thyroidism [11]. The presence of OCP is quite interesting. OCP is
a thermodynamically metastable phase and it transforms to apatite
spontaneously [12]. From a physiological point of view, this
compound has been proposed to participate as a precursor of
biological apatites. Also, regarding kidney stones, this compound
has been found in pregnant women for which the metabolism of
Ca
2+ is modified in order to build the bone network of the foetus
[13]. For these reasons, it seems of primary importance to
distinguish these different Ca
2+ phosphates in the tissues.
Another original aspect of our study comes from the
opportunity to use SR mFTIR spectroscopy for indirect diagnosis
of a genetic disease. Dihydroxyadenine crystals were found in four
patients (five biopsies in Table 1). Such crystals deposits in
parenchyma are pathognomonic of a rare disease, adenine
phosphoribosyltransferase deficiency, an inherited disease able to
induce recurrent kidney stones and/or kidney failure. Dihydrox-
yadenine is often too late identified in patients who have developed
renal insufficiency and sometimes after the crystal-induced
destruction of a kidney transplant. As recently emphasized, these
data suggest this disease could be less rare than commonly
reported [14]. In our series, two patients were diagnosed using
synchrotron examination of biopsies after renal impairment of the
grafted kidney. They were treated with allopurinol and they
recovered a large part of their kidney function. Such observations
underline the clinical interest of early identification of crystals in
the tissue.
Finally, high spatial resolution infrared mapping is a powerful
tool to study the kidney distribution of some poorly soluble drugs
and metabolites. It is well known that foscarnet crystallizes in
glomeruli [15]. Foscarnet (phosphonoformic acid) is a pyrophos-
phate analogue that inhibits the DNA polymerase of all herpes
viruses, which is commonly used in immuno-suppressed patients
(AIDS, grafted patients) who developed CMV infection. Through
SR-m FTIR, spectroscopy we observed sodium foscarnet crystals in
glomeruli in line with a previous study [16]. In addition, we found
in the cells of the proximal tubule an accumulation of apatite
crystals suggesting that the drug is locally metabolized by splitting
the bond between the two phosphate residues of foscarnet. To the
best of our knowledge, no data has been reported about associated
crystalline phases deposited within the cells of the tubules.
In conclusion, here, we give the first structural evidence of a
chemical diversity for mineral deposits in the kidney tissue. New
crystalline phases were described such as amorphous silica, sodium
hydrogen urate, methyl-1 uric acid and three different Ca
2+
Figure 3. Mapping and optical image of a birefringent structure. The poorly soluble foscarnet can be detected and quantified after a
mapping of the biopsy thanks to the characteristic peak at 936 cm
-1.
doi:10.1371/journal.pone.0028007.g003
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the first time, we underline the chemical heterogeneity of
intratissular calcifications.
Other striking results of this study concern the opportunity to
establish early medical diagnosis. Such approach should be
generalized when the usual techniques at the hospital are not
able to identify accurately pathological intratissular deposits. The
relatively high number of APRT deficiency cases identified from
dihydroxyadenine crystals, a disease easily treated with allopurinol
when correctly diagnosed, underlined the utmost clinical impor-
tance of identifying crystals in kidney biopsies in order to improve
the etiologic diagnosis of some renal impairments.
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